UFP TECHNOLOGIES INC (UFPT) UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
UFP Technologies, Inc. NASDAQ:UFPT Healthcare · Medical - Devices
AH Close $295.78 +0.00% vs close
AH Close $295.78 +0.00% vs close
All Press Release SEC Filings News
Press Release
UFP Packaging Launches All Boxed Up as Brand for Growing Corrugated Business
prnewswire.com • 12d ago SEC Filing ⚠ 3
UFPT: 8-K · other
UFP Technologies filed an 8-K under Item 7.01 (Regulation FD Disclosure) on August 24, 2026 to furnish updated August 2026 investor presentation materials it intends to use in meetings with investors and other audiences. No new financial results, transactions, or guidance changes were announced.
The deck highlights $603 million of 2025 revenue, up from $179 million in 2020 (3.4x growth), with adjusted operating margins expanding from 10.0% to 17.1% over that span. It reiterates 3-5 year targets of 12-18% annual revenue growth, 28-31% gross margins, and 17-20% adjusted operating margins.
Year-to-date through June 30, 2026, the company cited a 29.0% gross margin and 17.2% adjusted operating margin, alongside a market capitalization of roughly $2.5 billion as of August 17, 2026 and more than 5,000 team members across six countries.
The presentation's risk language flags dependence on two large customers, including Intuitive Surgical SARL, and references a previously disclosed cyber incident — but this filing is otherwise routine disclosure housekeeping for the small-cap medtech CDMO.
SEC 8-K • 2mo ago Press Release
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
UFP Technologies announced that CEO Mitchell Rock and CFO Ron Lataille will present and host 1-on-1 meetings at the 17th Annual Midwest IDEAS Investor Conference in Chicago on August 26, 2026.
The presentation is scheduled to begin at 8:35 AM CT and will be webcast live via the conference host's website and the company's investor relations page.
The IDEAS conferences provide independent regional venues for companies to present to investment professionals, with event sponsors collectively managing more than $200 billion in assets.
• 2mo ago AI analysis › SEC Filing ⚠ 7
UFPT: 10-Q · periodic report
UFP Technologies posted strong second-quarter 2026 results, with net sales up 15.1% to $174.0 million and organic growth of 12.4%, led by Surfaces and Support, Cardiovascular, Infection Control, and Orthopedics. Diluted EPS rose to $2.68 from $2.21 a year ago, and net income grew to $20.9 million from $17.2 million.
Gross margin expanded to 29.3% from 28.8% on operating efficiencies, though SG&A climbed 21.8% to $22.8 million, partly on share-based compensation tied to CEO transition costs. For the first half, sales rose 9.6% to $328.2 million with 6.8% organic growth and diluted EPS of $4.92.
On the balance sheet, cash fell to $9.0 million from $20.3 million at year-end as operating cash flow halved to $18.8 million, pressured by a $30.5 million receivables build from surging Q2 sales. The company carried $117.3 million of debt under its $275 million Bank of America credit facility at a roughly 5.0% weighted average rate and remains in covenant compliance.
Watch items include a February 2026 cyber incident that has not materially impacted operations but remains under investigation, ongoing inefficiencies from the AJR E-Verify-related labor issue, and heavy customer concentration, with the two largest customers accounting for 47.2% of Q2 sales combined.
SEC 10-Q • 2mo ago AI analysis › Press Release ● Major ⚠ 1
UFP Technologies Announces Record Q2 Results
UFP Technologies reported record Q2 results with net income of $20.9 million, up 21.4% year-over-year, on net sales of $174.0 million, which increased 15.1%.
Gross margin expanded to 29.3% from 28.8% in the prior year, while GAAP EPS rose to $2.68 and adjusted EPS reached $2.92, both up from the prior year.
Year-to-date sales grew 9.6% to $328.2 million, driven by 12.4% organic sales growth in the quarter and strong contributions across the MedTech platform.
• 2mo ago AI analysis › Press Release
UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026
UFP Technologies announced that it will report its second quarter 2026 financial results on Monday, August 3, after the market closes.
A conference call is scheduled for the following day, Tuesday, August 4, at 8:30 AM ET to discuss the results.
Investors may access the live webcast or a replay via the company’s investor relations website.
• 2mo ago AI analysis › Press Release
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 26th Annual New Ideas Summer Conference
UFP Technologies announced that CEO Mitchell Rock and CFO Ron Lataille will attend the CJS Securities 26th Annual New Ideas Summer Conference in White Plains, NY on July 9, 2026.
Management will conduct presentations and host one-on-one meetings with investors during the event.
UFP Technologies operates as a contract development and manufacturing organization specializing in medical devices and sterile packaging.
• 3mo ago AI analysis › SEC Filing
UFPT: 8-K · leadership change
UFP Technologies Inc. appointed Mitchell C. Rock as Chief Executive Officer and Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026. Rock was also appointed to the Board of Directors, which increased its size from seven to eight members to accommodate the vacancy.
Stafford, previously Executive Vice President and Chief Legal Officer at Littelfuse Inc., receives a base salary of $400,000 and an equity grant valued at $650,000. The Compensation Committee also granted $650,000 in stock units to Rock and $1,000,000 in stock units to CFO Ronald J. Lataille to align executive incentives with the company's growth strategy.
The appointments follow the announced retirement of Christopher P. Litterio, who served as General Counsel and SVP of HR. Stafford’s background in M&A and legal leadership is highlighted as supporting UFP Technologies’ continued expansion through strategic acquisitions.
SEC 8-K • 4mo ago AI analysis › SEC Filing
UFPT: 8-K · other
UFP Technologies filed an 8-K under Item 7.01 to disclose updated investor presentation materials used for meetings with investors and other interested parties. The presentation highlights the company's 2025 revenue of $603 million and a market capitalization of approximately $1.7 billion as of early June 2026.
The materials outline a strategic focus on high-growth medical device segments, including robotic-assisted surgery and infection control, with a target of 12-18% blended annual revenue growth. Management emphasizes a decentralized operating model supported by customer-centric acquisitions and disciplined capital allocation.
The filing includes standard forward-looking statement disclaimers and risk factors, noting dependencies on large customers such as Intuitive Surgical SARL and risks related to global trade and supply chain disruptions. No new material agreements or financial results were announced in this filing.
SEC 8-K • 4mo ago SEC Filing
UFPT: 8-K · proxy statement
UFP Technologies, Inc. reported the results of its Annual Meeting of Stockholders held on June 4, 2026. All seven director nominees were elected to serve until the 2027 Annual Meeting, with each receiving over 90% of the votes cast in favor.
Stockholders also approved the advisory vote on executive compensation, with approximately 89.8% voting in favor. Additionally, shareholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with over 98% of votes cast in favor.
SEC 8-K • 4mo ago Press Release
UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
UFP Technologies will present at the 16th Annual East Coast IDEAS Investor Conference on June 10, 2026.
CEO Mitchell Rock and CFO Ron Lataille are scheduled to speak at 7:55 AM ET at The Westin Times Square in New York.
The presentation will be webcast via the conference host’s website and the company’s investor relations page.
• 4mo ago AI analysis › Press Release
UFP Technologies Names Ryan Stafford General Counsel and Senior Vice President of Human Resources
UFP Technologies appointed Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026.
Stafford succeeds Chris Litterio, who is retiring after playing a pivotal role in the company’s growth.
Stafford brings nearly three decades of experience from high-growth public companies, most recently serving as Chief Legal Officer and head of M&A at Littelfuse, Inc.
• 4mo ago AI analysis › SEC Filing
UFPT: 8-K · leadership change
UFP Technologies, Inc. announced that Christopher P. Litterio, its General Counsel, Secretary, and Senior Vice President of Human Resources, plans to retire from the company.
Litterio informed the company of his retirement plans on May 19, 2026, and will remain with the firm for a transition period before departing.
The filing was signed by CFO Ronald J. Lataille, indicating no change in the company's top financial leadership at this time.
SEC 8-K • 4mo ago AI analysis › Press Release ● Major ⚠ 3
UFP Technologies Announces Strong Q1 Results
UFP Technologies reported Q1 net sales of $154.2 million, up 4.1% year-over-year, driven by a 5.9% increase in medical sales that offset a 15% decline in non-medical revenue.
Net income increased 1.8% to $17.5 million, with GAAP EPS of $2.24, though earnings growth lagged sales due to start-up costs and labor inefficiencies.
Management remains bullish on the second half, citing a strong backlog and the opening of two new facilities in the Dominican Republic to support growth in robotic surgery and patient handling.
• 5mo ago AI analysis › Press Release
UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
UFP Technologies announced it will report its first quarter 2026 financial results on Monday, May 4, 2026, after the market close.
A conference call to discuss the results is scheduled for the following day, Tuesday, May 5, 2026, at 8:30 AM Eastern time.
The company operates as a contract development and manufacturing organization specializing in single-use and single-patient medical devices and packaging.
• 5mo ago AI analysis › 
